SS
CRMD icon

Steve Schonfeld’s CorMedix CRMD Stock Holding History

Steve Schonfeld’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+30,153
New +$238K ﹤0.01% 2133
2026
Q1 		– Sell
-43,431
Closed -$505K – 2297
2025
Q4 		$505K Buy
43,431
+22,283
+105% +$246K ﹤0.01% 1394
2025
Q3 		$246K Buy
21,148
+5,266
+33% +$63.7K ﹤0.01% 1892
2025
Q2 		$196K Buy
+15,882
New +$175K ﹤0.01% 1793
2023
Q3 		– Sell
-14,255
Closed -$56.5K – 1851
2023
Q2 		$56.5K Buy
+14,255
New +$70.5K ﹤0.01% 1800

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steve Schonfeld's CRMD Position: Q2 2026 in Review

Steve Schonfeld opened a new position in CorMedix (CRMD) in Q2 2026: 30,153 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #2133 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in CRMD as recently as Q4 2025.

Steve Schonfeld first reported a position in CRMD in Q2 2023 and has held it in 5 quarters since. The position peaked at $505K in Q4 2025. 192 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Steve Schonfeld held 30,153 shares of CorMedix worth $237K as of Q2 2026.
  • CorMedix was a new Steve Schonfeld position in Q2 2026.
  • CorMedix made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2133 holding.
  • Steve Schonfeld first reported a position in CorMedix in Q2 2023 and has held it in 5 quarters since.
  • Steve Schonfeld's CorMedix position peaked at $505K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.